Logotype for Willis Towers Watson plc

Willis Towers Watson (WLTW) Q2 2025 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for Willis Towers Watson plc

Q2 2025 earnings summary

5 Nov, 2025

Executive summary

  • Achieved 5% organic revenue growth and 150 basis points of adjusted operating margin expansion in Q2 2025, with adjusted EPS up 20% year-over-year to $2.86 and diluted EPS up 144% to $3.32.

  • Net income rose 135% to $332 million for the quarter, driven by cost reductions and operational efficiencies.

  • Strategic focus on performance acceleration, efficiency, and portfolio optimization, with technology and AI investments delivering measurable efficiency gains.

  • Returned $500 million to shareholders via share repurchases and paid $91 million in dividends in Q2 2025.

  • Completed divestiture of TRANZACT on December 31, 2024, impacting year-over-year revenue comparisons and creating a $1.14 headwind to adjusted EPS for 2025.

Financial highlights

  • Q2 2025 revenue was $2.26 billion, flat year-over-year; organic revenue up 5%.

  • Net income for Q2 2025 was $332 million, up from $142 million in Q2 2024; diluted EPS was $3.32.

  • Adjusted operating margin reached 18.5% in Q2 2025, up 150 basis points year-over-year.

  • Adjusted EBITDA for Q2 2025 was $470 million (20.8% margin), up from $445 million (19.6%).

  • Free cash flow for the first half of 2025 was $217 million, down from $305 million in the prior year due to higher incentive costs, tax payments, and the absence of TRANZACT inflows.

Outlook and guidance

  • On track to deliver full-year 2025 guidance: mid-single-digit organic growth, adjusted operating margin expansion, adjusted EPS growth, and free cash flow margin improvement.

  • Expecting ~$1.5 billion in share repurchases in 2025, subject to market conditions and M&A opportunities.

  • Risk & Broking expected to achieve mid to high single-digit organic growth and ~100 basis points of average annual margin expansion over the next three years.

  • Health, Wealth & Career expected to maintain mid-single-digit revenue growth and incremental margin expansion.

  • Foreign currency expected to provide a $0.05 tailwind to adjusted diluted EPS in 2025.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more